Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma-Reference-Cited by-同舟云学术

Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma

Published:2014-12-23 Issue:7 Volume:121 Page:1128-1137
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Herman Joseph M.¹,Chang Daniel T.²,Goodman Karyn A.³,Dholakia Avani S.¹,Raman Siva P.⁴,Hacker‐Prietz Amy¹,Iacobuzio‐Donahue Christine A.⁵,Griffith Mary E.¹,Pawlik Timothy M.⁶,Pai Jonathan S.²,O'Reilly Eileen⁷,Fisher George A.⁸,Wild Aaron T.¹,Rosati Lauren M.¹,Zheng Lei⁹,Wolfgang Christopher L.⁶,Laheru Daniel A.⁹,Columbo Laurie A.²,Sugar Elizabeth A.¹⁰,Koong Albert C.²

Affiliation:

1. Department of Radiation Oncology & Molecular Radiation SciencesSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of MedicineBaltimore Maryland

2. Department of Radiation Oncology, Stanford Cancer Institute, Stanford University School of MedicineStanford California

3. Department of Radiation OncologyMemorial Sloan Kettering Cancer CenterNew York New York

4. Department of RadiologySidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of MedicineBaltimore Maryland

5. Department of PathologySidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of MedicineBaltimore Maryland

6. Department of SurgerySidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of MedicineBaltimore Maryland

7. Department of Medical OncologyMemorial Sloan Kettering Cancer CenterNew York New York

8. Department of Medical OncologyStanford Cancer Institute, Stanford University School of MedicineStanford California

9. Department of Medical OncologySidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of MedicineBaltimore Maryland

10. Department of Biostatistics and EpidemiologyJohns Hopkins University School of MedicineBaltimore Maryland

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.29161

Reference32 articles.

1. Cancer statistics, 2012

2. Pancreatic Adenocarcinoma, Version 2.2012

3. Randomized Phase III Multi-Institutional Study of TNFerade Biologic With Fluorouracil and Radiotherapy for Locally Advanced Pancreatic Cancer: Final Results

4. Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

5. A Phase I/II Trial of Intensity Modulated Radiation (IMRT) Dose Escalation With Concurrent Fixed-dose Rate Gemcitabine (FDR-G) in Patients With Unresectable Pancreatic Cancer

Cited by 429 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical indications for carbon-ion radiotherapy in the UK: A critical review;Radiography;2024-03

2. Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label phase 2 study;Radiotherapy and Oncology;2024-02

3. Stereotactic body radiotherapy in pancreatic adenocarcinoma;Hepatobiliary & Pancreatic Diseases International;2024-02

4. Initial Observation of Contrast Profiles for 2-Dimensional and 3-Dimensional Magnetic Resonance Imaging Sequences in Magnetic Resonance–Guided Radiation Therapy for Locally Advanced Pancreatic Cancer;Advances in Radiation Oncology;2024-01

5. Clinical practice guidelines for interventional treatment of pancreatic cancer;Recent Advances in Nanocarriers for Pancreatic Cancer Therapy;2024